Financial Year |
March 31 2023 |
Monetary Funds |
80,439,928.44 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
2,990,152.50 |
Accounts Receivable |
577,191,501.30 |
Advances to Suppliers |
541,967,365.68 |
Other Receivables |
25,190,194.81 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
13,539.80 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
12,591,050.60 |
Total Current Assets |
1,248,599,735.80 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
14,187,987.90 |
Investment Properties |
-- |
Fixed Assetes |
5,305,631.11 |
Under-construction Projects |
-- |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
5,589,206.55 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
1,126,906.52 |
Deferred Income Tax Assets |
50,349,855.43 |
Other Non-Current Assets |
-- |
Sub-Total of Non-Current Assets |
98,872,305.41 |
Total Assets |
1,347,472,041.21 |
Short-Term Loans |
170,222,541.55 |
Trading Financial liabilities |
955,413.41 |
Notes Payable |
-- |
Accounts Payable |
389,993,620.56 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
29,653,291.45 |
Taxes Payable |
4,120,432.63 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
13,425,745.68 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
96,379,183.39 |
Other Current Liabilities |
32,511,796.43 |
Sub-Total of Current Liabilities |
1,149,079,996.98 |
Long-term Loans |
40,043,750.00 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
1,631,638.46 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
44,267,486.65 |
Total Liabilities |
1,193,347,483.63 |
Paid-In Capital(Or Share Stock) |
267,862,900.00 |
Capital Surplus |
3,819,194.29 |
Surplus Reserve |
16,418,070.33 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
-135,857,746.04 |
Minority Stockholder's Interest |
17,339.00 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
154,107,218.58 |
Owner's Equity(Stockholder's Equity) |
154,124,557.58 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
1,347,472,041.21 |